Cardiac safety implications of hNav1.5 blockade and a framework for preclinical evaluation
The human cardiac sodium channel (hNav1.5, encoded by the SCN5A gene) is critical for action potential generation and propagation in the heart. Drug-induced sodium channel inhibition decreases the rate of cardiomyocyte depolarization and consequently conduction velocity and can have serious implicat...
Main Authors: | Gul eErdemli, Albert M Kim, Haisong eJu, Clayton eSpringer, Robert C Penland, Peter K Hoffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2012-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2012.00006/full |
Similar Items
-
Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine
by: Sandra Dhifallah, et al.
Published: (2018-07-01) -
CACHET-CADB: A Contextualized Ambulatory Electrocardiography Arrhythmia Dataset
by: Devender Kumar, et al.
Published: (2022-07-01) -
Blockade of NaV1.8 Increases the Susceptibility to Ventricular Arrhythmias During Acute Myocardial Infarction
by: Baozhen Qi, et al.
Published: (2021-08-01) -
Contrasting Nav1.8 Activity in Scn10a−/− Ventricular Myocytes and the Intact Heart
by: Dina Myers Stroud, et al.
Published: (2016-10-01) -
Arrhythmia-Induced Cardiomyopathy. A Palestinian Experience
by: Abdelrhman Janem, et al.
Published: (2022-12-01)